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Dietary aflatoxin exposure and impaired growth in young
children from Benin and Togo: cross sectional study
Y Y Gong, K Cardwell, A Hounsa, S Egal, P C Turner, A J Hall, C P Wild
Fetal and early childhood environment, including the
nutritional status of the pregnant mother and the
infant, are considered critical for growth and risk of
disease in later life.1 Many people in developing coun›
tries are not only malnourished but also chronically
exposed to high levels of toxic fungal metabolites
(mycotoxins). One family of mycotoxins, the aflatoxins,
are carcinogenic and immunotoxic and cause growth
retardation in animals.2 Aflatoxins contaminate staple
foods in West Africa, particularly maize and ground›
nuts, as a result of hot, humid storage conditions that
promote fungal growth. High exposure to aflatoxins
occurs throughout childhood in the region,3 4 suggest›
ing that growth and development could be critically
affected. We assessed exposure to aflatoxins in relation
to anthropometric measures in children in Benin and
Togo.
Methods and results
We studied 480 children (aged 9 months to 5 years)
from 16 villages in four geographic zones (four in each
zone): Sudan savannah, north Guinea savannah, south
Guinea savannah, and coastal savannah. The Ministries
for Health in Benin and Togo gave ethical approval,
and parents gave informed consent. We determined
What is already known on this topic
Delay in presentation and assessment of patients
with suspected stroke prevents the possible
benefits from thrombolysis being achieved
Little is known about the presentation and early
management of patients with acute stroke in the
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What this study adds
Most patients with suspected stroke in the United
Kingdom arrive at hospital within six hours of the
onset of symptoms
Not all patients are evaluated by a senior doctor
within three hours of arrival at hospital and most
do not undergo computed tomography
The potential for thrombolysis in patients with
acute stroke can be improved significantly by
greater use of emergency services and expediting
evaluation and investigations by doctors
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weight for age, height for age, and weight for height z
scores, according to the median value of a World
Health Organization reference population. A z score
<2 is classified as malnutrition, and <3 represents
severe malnutrition. We also determined weaning
status and the socioeconomic status of the mother and
family. We assessed aflatoxin exposure over the
previous two to three months by measuring aflatoxin
bound to albumin in blood.3
We detected aflatoxin›albumin adducts in 475/479
(99%) samples (one sample missing), with a geometric
mean concentration of 32.8 (range 5›1064) pg/mg
albumin. Aflatoxin›albumin concentration increased
with age up to 3 years, after which it reached a plateau.
In the 302 children aged 3 years or under, the mean
concentration was 2.5›fold higher in fully weaned
children (45.6 pg/mg; 95% confidence interval 38.8 to
53.7) than in those still partially breast fed (18.0
pg/mg; 15.2 to 21.3). In a multivariable model adjust›
ing for age, sex, socioeconomic status, and agro›
ecological zone, weaning status was significantly
associated with aflatoxin›albumin concentration
(P=0.0001).
Prevalence of malnutrition was 33% for stunting
(height for age z score <2), 29% for being
underweight (weight for age z score <2), and 6% for
wasting (weight for height z score <2). Children with
stunting or who were underweight had 30›40% higher
mean aflatoxin›albumin concentrations. After adjust›
ment as above, the negative correlation between indi›
vidual aflatoxin›albumin concentration and each of
the three growth parameters was highly significant
(P=0.001 for height for age, P=0.005 for weight for
age, and P=0.047 for weight for height). In a categori›
cal analysis, the association with aflatoxin›albumin
concentration was again significant, with clear
dose›response relations with height for age and
weight for age z scores (figure).
Comment
This study reveals a striking association between
exposure to aflatoxin in children and both stunting
(a reflection of chronic malnutrition) and being
underweight (an indicator of acute malnutrition). In
West Africa, people are chronically exposed to high
levels of aflatoxins starting in utero and continuing
throughout life.4 In this study, children still partially
breast fed had lower exposure, almost certainly
reflecting lower toxin levels in milk than in weaning
and family foods. Thus growth faltering occurs at a
time of change to solid foods, when there is
co›exposure to aflatoxin and a plethora of infectious
hazards (for example, malaria, diarrhoea, respiratory
infections). Whether the association between aflatoxin
exposure and impaired growth is a direct result of
aflatoxin toxicity or reflects consumption of fungus
affected food of poor nutritional quality cannot be
confirmed from the cross sectional design. However,
these observations emphasise the need to investigate
this question and to develop strategies to reduce
exposure to aflatoxin, possibly involving interventions
targeted at the post›weaning period in African
children.5
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Concentrations of aflatoxin›albumin adduct categorised into four
groups for height for age and weight for age z scores on the basis
of the WHO classification of malnutrition (z score <2) and severe
malnutrition (<3). Geometric mean adduct concentrations are
shown, with 95% confidence intervals, adjusted for weaning status,
agro›ecological zone, and socioeconomic status. Height for age and
weight for age z scores were significantly associated with
aflatoxin›albumin concentration (trend test: F=15.19, P=0.0001,
r2 =0.3766; and F=8.48, P=0.0038, r2 =0.3680).
What is a good doctor and how
can we make one?
We want your views on this for a future theme issue
of the BMJ.
Governmental and professional regulation now
operates in most aspects of doctors’ lives yet
doctors themselves have had little opportunity to
air their views on what they think makes a good
doctor or how good doctors should be made.
Contribute to this debate now by visiting our
home page (bmj.com) or going direct to the debate
at www.bmj.com/gooddoctor
All submissions will be published on the website
and a selection of the best letters will be published
in the theme issue that will be devoted to this topic
in September 2002.
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